Company has B S R & Associates LLP as its auditors. As on 31-12-2024, the company has a total of 17.91 Crore shares outstanding.Natco Pharma Share Price Today is Rs. 804.95. On previous day, the Natco ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development manufacturing and marketing of Finished Dosage Formulations (FDF) and Active ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Competition page helps you compare Natco Pharma Ltd. with its sector peers on key parameters.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.

Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.

Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April 1982. Pursuant to the Scheme of Amalgamation name of the Company was changed from Tasc Pharmaceuticals ...

Natco Pharma Limited is a vertically ... of 1 crore Equity Shares at the issue price of Rs 915 per Equity (including a premium of Rs. 913 per Equity Share) upon the closure of the issue, to ...

2,000 Cr PAT in FY25 & FY26 despite uncertainties. In Friday’s trading session, Natco Pharma‘s share price was down by 3 percent and closed at Rs. 797.70 per share from the previous close of Rs.